188 filings
6-K
NLSP
NLS Pharmaceutics Ltd
19 Apr 24
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
5:16pm
6-K
NLSP
NLS Pharmaceutics Ltd
15 Apr 24
Report of Foreign Private Issuer
4:01pm
6-K
NLSP
NLS Pharmaceutics Ltd
8 Apr 24
Report of Foreign Private Issuer
4:11pm
D
NLSP
NLS Pharmaceutics Ltd
3 Apr 24
$1.75 mm in equity / options / securities to be acquired, sold $1.75 mm, 2 investors
4:01pm
SC 13G
Lind Global Fund II LP
27 Mar 24
NLS Pharmaceutics / Lind Global Fund II ownership change
7:37pm
424B5
NLSP
NLS Pharmaceutics Ltd
22 Mar 24
Prospectus supplement for primary offering
10:24am
6-K
NLSP
NLS Pharmaceutics Ltd
21 Mar 24
NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering
5:14pm
6-K
NLSP
NLS Pharmaceutics Ltd
20 Mar 24
Report of Foreign Private Issuer
12:58pm
6-K
NLSP
NLS Pharmaceutics Ltd
20 Mar 24
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation
9:06am
6-K
NLSP
NLS Pharmaceutics Ltd
19 Mar 24
Report of Foreign Private Issuer
6:41pm
6-K
NLSP
NLS Pharmaceutics Ltd
14 Mar 24
Report of Foreign Private Issuer
9:00am
6-K
NLSP
NLS Pharmaceutics Ltd
11 Mar 24
Report of Foreign Private Issuer
4:01pm
6-K
NLSP
NLS Pharmaceutics Ltd
23 Feb 24
Report of Foreign Private Issuer
4:00pm
SC 13G/A
NLSP
NLS Pharmaceutics Ltd
12 Feb 24
NLS Pharmaceutics / YA II PN ownership change
4:37pm
6-K
NLSP
NLS Pharmaceutics Ltd
12 Jan 24
NLS Pharmaceutics Announces Receipt of Notice of Deficiency with Nasdaq Continued Listing Requirements
5:03pm
6-K
NLSP
NLS Pharmaceutics Ltd
29 Dec 23
Report of Foreign Private Issuer
4:30pm
6-K
NLSP
NLS Pharmaceutics Ltd
22 Dec 23
Report of Foreign Private Issuer
4:02pm
6-K
NLSP
NLS Pharmaceutics Ltd
6 Dec 23
Unaudited Interim Condensed Financial Statements
4:44pm
6-K
NLSP
NLS Pharmaceutics Ltd
4 Dec 23
NLS Pharmaceutics Announces Election of Additional Board Members
4:45pm
6-K
NLSP
NLS Pharmaceutics Ltd
4 Dec 23
Report of Foreign Private Issuer
4:00pm